granisetron + granisetron
ApprovedCompleted 1 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Post-Operative Nausea and Vomiting
Conditions
Post-Operative Nausea and Vomiting
Trial Timeline
Apr 1, 2007 → Dec 1, 2007
NCT ID
NCT00231478About granisetron + granisetron
granisetron + granisetron is a approved stage product being developed by Roche for Post-Operative Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT00231478. Target conditions include Post-Operative Nausea and Vomiting.
What happened to similar drugs?
3 of 11 similar drugs in Post-Operative Nausea and Vomiting were approved
Approved (3) Terminated (0) Active (8)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00231478 | Approved | Completed |
Competing Products
18 competing products in Post-Operative Nausea and Vomiting